These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 956895)

  • 21. [Proposal for the preparation and testing of the 99mTc-Sn-gluconate complex for renal scintigraphy. II. Simplified method].
    Charamza O
    Cesk Farm; 1975 Nov; 24(9):405. PubMed ID: 1218410
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyridine-containing 6-hydrazinonicotinamide derivatives as potential bifunctional chelators for 99mTc-labeling of small biomolecules.
    Purohit A; Liu S; Ellars CE; Casebier D; Haber SB; Edwards DS
    Bioconjug Chem; 2004; 15(4):728-37. PubMed ID: 15264859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of a 99mTc-Sn-MAA kit for use in nuclear medicine.
    Lyster DM; Scott JR; Mincey EK; Morrison RT
    J Nucl Med; 1974 Mar; 15(3):198-9. PubMed ID: 4813230
    [No Abstract]   [Full Text] [Related]  

  • 24. [Labeling of unnatural amino acids with 99mTc and tissue distribution of the labeled products in mice].
    Tamemasa O; Goto R; Takeda A
    Radioisotopes; 1981 Dec; 30(12):674-8. PubMed ID: 7335909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 99mTc-tetracyclines: preparation and biological evaluation.
    Dewanjee MK; Fliegel C; Treves S; Davis MA
    J Nucl Med; 1974 Mar; 15(3):176-82. PubMed ID: 4204979
    [No Abstract]   [Full Text] [Related]  

  • 26. Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation.
    Eisenhut M; Lehmann WD; Becker W; Behr T; Elser H; Strittmatter W; Steinsträsser A; Baum RP; Valerius T; Repp R; Deo Y
    J Nucl Med; 1996 Feb; 37(2):362-70. PubMed ID: 8667077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of high performance liquid chromatography for the structural identification of technetium-99m radiopharmaceuticals at the NCA level.
    Baldas J; Bonnyman J; Ivanov Z
    J Nucl Med; 1989 Jul; 30(7):1240-8. PubMed ID: 2738705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S; Kalincák M; Machán V
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 99mTc labeling of proteins: initial evaluation of a novel diaminedithiol bifunctional chelating agent.
    Baidoo KE; Scheffel U; Lever SZ
    Cancer Res; 1990 Feb; 50(3 Suppl):799s-803s. PubMed ID: 2297727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands.
    Liu S; Edwards DS; Looby RJ; Harris AR; Poirier MJ; Barrett JA; Heminway SJ; Carroll TR
    Bioconjug Chem; 1996; 7(1):63-71. PubMed ID: 8741992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of photoactivation in the preparation of radiopharmaceuticals. III. Human serum albumin labelled with technetium (99mTc)].
    Komárek P; Kleisner I; Konopková M; Komárková I
    Ceska Slov Farm; 1997 Oct; 46(5):217-21. PubMed ID: 9600144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 99mT-c-pyridoxylidene glutamate a radiopharmaceutical for the hepatobiliary system.
    Noronha OP; Sewatkar AB; Ganatra RD; Subramanian G
    Nuklearmedizin; 1976 Apr; 15(2):71-4. PubMed ID: 1272814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Splenic imaging with 99mTc-labeled erythrocytes: a comparative study of cell-damaging methods.
    Hamilton RG; Alderson PO; Harwig JF; Siegel BA
    J Nucl Med; 1976 Dec; 17(12):1038-43. PubMed ID: 993833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of an instant kit for preparation of 99mTc-MAA for lung scanning.
    Chandra R; Shamoun J; Braunstein P; DuHov OL
    J Nucl Med; 1973 Sep; 14(9):702-5. PubMed ID: 4724342
    [No Abstract]   [Full Text] [Related]  

  • 35. 99mTc-neolactosylated human serum albumin for imaging the hepatic asialoglycoprotein receptor.
    Jeong JM; Hong MK; Lee J; Son M; So Y; Lee DS; Chung JK; Lee MC
    Bioconjug Chem; 2004; 15(4):850-5. PubMed ID: 15264873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrophosphate derivatives of glucose: synthesis and labeling with 99mTc.
    Wang TS; Hosain R; Spencer RP; Hosain F
    Nuklearmedizin; 1977 Apr; 16(2):89-90. PubMed ID: 195272
    [No Abstract]   [Full Text] [Related]  

  • 37. Time-dependent characteristics of Sn-complexes for preparing 99mTc-labelled radiopharmaceuticals and their bioavailabilities--a review.
    Noronha OP
    Nuklearmedizin; 1978 Jul; 17(3):110-25. PubMed ID: 704364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of redox polymers for insulin labeling with technetium (99mTc)].
    Komárek P; Kleisner I; Konopková M; Komárková I
    Ceska Slov Farm; 1999 Sep; 48(5):218-20. PubMed ID: 10566241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 99mTc-labelled hepatobiliary agents-- 99mTc-pyridoxylidene glutamate (99mTc-PG) and 99mTc-Sn-lidocaine iminodiacetic acid (99mTc-Sn-LIDA).
    Sewatkar AB; Noronha OP
    Nuklearmedizin; 1976 Dec; 15(6):290-3. PubMed ID: 1012924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of radiopharmaceutical-enclosing lipid-protein vesicles formed from native plasma components.
    Dunnick JK; Kriss JP
    J Nucl Med; 1977 Feb; 18(2):183-6. PubMed ID: 833665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.